These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 26561725

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J, Wang BM, Schwendeman SP.
    Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH, DeLuca PP.
    Pharm Res; 2005 May; 22(5):736-42. PubMed ID: 15906168
    [Abstract] [Full Text] [Related]

  • 10. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK, Park TG.
    J Control Release; 2004 Jul 23; 98(1):115-25. PubMed ID: 15245894
    [Abstract] [Full Text] [Related]

  • 11. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB, Na DH, Thanoo BC, DeLuca PP.
    Int J Pharm; 2005 Jun 13; 297(1-2):62-72. PubMed ID: 15885939
    [Abstract] [Full Text] [Related]

  • 12. Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies.
    Schwach G, Oudry N, Delhomme S, Lück M, Lindner H, Gurny R.
    Eur J Pharm Biopharm; 2003 Nov 13; 56(3):327-36. PubMed ID: 14602174
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
    Shirangi M, Najafi M, Rijkers DT, Kok RJ, Hennink WE, van Nostrum CF.
    Bioconjug Chem; 2016 Mar 16; 27(3):576-85. PubMed ID: 26726953
    [Abstract] [Full Text] [Related]

  • 14. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
    Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V.
    J Pharm Sci; 2004 Jul 16; 93(7):1804-14. PubMed ID: 15176068
    [Abstract] [Full Text] [Related]

  • 15. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S, Janoria KG, Pal D, Mitra AK.
    J Ocul Pharmacol Ther; 2007 Jun 16; 23(3):264-74. PubMed ID: 17593010
    [Abstract] [Full Text] [Related]

  • 16. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR, Trehan A.
    Drug Deliv; 2005 Jun 16; 12(3):133-9. PubMed ID: 16025842
    [Abstract] [Full Text] [Related]

  • 17. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Schwendeman SP.
    Drug Deliv Transl Res; 2022 Mar 16; 12(3):695-707. PubMed ID: 34215997
    [Abstract] [Full Text] [Related]

  • 18. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
    Jiang G, Woo BH, Kang F, Singh J, DeLuca PP.
    J Control Release; 2002 Feb 19; 79(1-3):137-45. PubMed ID: 11853925
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy.
    Lim SM, Eom HN, Jiang HH, Sohn M, Lee KC.
    J Pharm Sci; 2015 Jan 19; 104(1):72-80. PubMed ID: 25407390
    [Abstract] [Full Text] [Related]

  • 20. Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits.
    Comets E, Mentré F, Kawai R, Nimmerfall F, Marbach P, Vonderscher J.
    J Pharm Sci; 2000 Sep 19; 89(9):1123-33. PubMed ID: 10944377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.